Status:
UNKNOWN
Real-life Experience of the Use of Isomers as METPURE XL (S (-) Metoprolol Succinate) for Evaluation of Efficacy, Safety and Tolerability in the Management of Cardiovascular Disease in Colombian Patients
Lead Sponsor:
Closter Pharma
Conditions:
Hypertension
Coronary Disease
Eligibility:
All Genders
18+ years
Brief Summary
This is a Phase 4, observational, open study in patients who their doctor has prescribe METPURE XL (S (-)metoprolol succinate)by clinical practice. No medication was provided by the sponsor. The plann...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients who were prescibed with s(-)metoprolol succinate(25mg, 50mg), depending on their clinical condition and use locally approved will be eligible to participate in this study
Exclusion
Key Trial Info
Start Date :
August 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 1 2012
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT01426594
Start Date
August 1 2011
End Date
March 1 2012
Last Update
August 31 2011
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Country Club de Bogota
Bogotá, Colombia